BlackRock Greater Europe Investment Trust plc (LON:BRGE) has announced its portfolio holdings as at 30 September 2022: To discover more about the BlackRock Greater Europe Investment..
BlackRock Sustainable American Income Trust plc (LON:BRSA) has announced its portfolio holdings as at 30 September 2022: Click here to learn more about BlackRock Sustainable American Income..
Fidelity Japan Trust (LON:FJV) is the topic of conversation when Hardman and Co’s Analyst Mark Thomas caught up with DirectorsTalk for an exclusive interview. Q1: You..
BlackRock Income and Growth Investment Trust plc (LON:BRIG) has announced its portfolio holdings as at 30 September 2022: For more information on the BlackRock Income and..
AMTE Power Plc (LON:AMTE, a leading developer and manufacturer of lithium-ion and sodium-ion battery cells for specialist markets, has announced that, following the passing of the..
BlackRock Latin American Investment Trust plc (LON:BRLA) has announced its portfolio holdings as at 30 September 2022: To learn more about the BlackRock Latin American Investment..
BlackRock Smaller Companies Trust plc (LON:BRSC) has announced its portfolio holdings as at 30 September 2022: To learn more about the BlackRock Smaller Companies Trust plc..
hVIVO plc (LON:HVO) a rapidly growing specialist contract research organisation (CRO) and world leader in testing infectious and respiratory disease products using human challenge clinical trials,..
Morgan Advanced Materials plc (LON:MGAM), the global manufacturer of advanced carbon and ceramic materials for complex and technologically demanding applications, has announced today its scheduled trading..
Miton UK Microcap Trust plc (LON:MINI) Co-Fund Manager Gervais Williams caught up with DirectorsTalk to discuss their portfolio company TruFin plc. Q1: Are there certain companies..
Coats Group plc (LON:COA), the world’s leading industrial thread and global footwear component manufacturer, has announced that Heather Lawrence will join the Board as a Non-Executive..
Nuformix plc (LON:NFX), a pharmaceutical development company targeting unmet medical needs in fibrosis and oncology via drug repurposing, has announced that the Company will be hosting..
